Forian Inc. (NASDAQ:FORA - Get Free Report)'s share price rose 8.3% during trading on Thursday . The company traded as high as $2.16 and last traded at $2.16. Approximately 12,387 shares were traded during mid-day trading, a decline of 26% from the average daily volume of 16,764 shares. The stock had previously closed at $1.99.
Forian Stock Performance
The company has a market capitalization of $66.93 million, a PE ratio of -23.83 and a beta of 1.03. The firm's 50-day simple moving average is $2.00 and its 200 day simple moving average is $2.12.
Forian (NASDAQ:FORA - Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The company reported ($0.04) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.06). The firm had revenue of $7.06 million during the quarter, compared to analyst estimates of $5.37 million.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of FORA. Elser Financial Planning Inc purchased a new stake in shares of Forian during the 4th quarter valued at $1,151,000. Virtu Financial LLC acquired a new stake in Forian during the 4th quarter valued at $30,000. Renaissance Technologies LLC increased its position in shares of Forian by 48.9% during the fourth quarter. Renaissance Technologies LLC now owns 35,301 shares of the company's stock worth $73,000 after acquiring an additional 11,601 shares during the last quarter. Finally, Oracle Investment Management Inc. raised its position in shares of Forian by 0.7% in the 4th quarter. Oracle Investment Management Inc. now owns 1,366,107 shares of the company's stock valued at $2,814,000 after purchasing an additional 10,000 shares in the last quarter. 19.25% of the stock is currently owned by institutional investors and hedge funds.
About Forian
(
Get Free Report)
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Featured Stories
Before you consider Forian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.
While Forian currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
